Both in pretreatment CRC cells of TRG4 patients and in post-treatment radiation-resistant CRC cells, an analysis of miRNAs expression revealed that miR-622 expression is significantly higher compared, respectively, to pretreatment CRC cells of TRG1–3 patients and post-treatment radiation-sensitive CRC cells. This evidence concerns the gene NXN and colorectal carcinoma.